• Aucun résultat trouvé

on the subject of blood and blood products; Recognizing the technical, managerial, financial and ethical complexities of the situation, particularly in developing countries

N/A
N/A
Protected

Academic year: 2022

Partager "on the subject of blood and blood products; Recognizing the technical, managerial, financial and ethical complexities of the situation, particularly in developing countries"

Copied!
1
0
0

Texte intégral

(1)

世 界 銜 生 組 織 執 行 委 貝 會 决 議 y u ^ ^ 丨 J ^ 1 1 J p R E S O L U T I O N O F T H E E X E C U T I V E B O A R D O F T H E W H O R É S O L U T I O N D U C O N S E I L E X É C U T I F D E L ' O M S Р Е З О Л Ю Ц И Я И С П О Л Н И Т£ “Г Ч О Г О К О М И Т Е Т А ВОЗ R E S O L U C I O N D E L С О M S L J О E J E C U T I V O D E L A O M S

Seventy-ninth Session Agenda item 7.2

BLOOD AND BLOOD PRODUCTS

The Executive B o a r d ,

Reiterating its support for resolution WHA28.72;

Having considered the reports of the Programme Committee and of the Director-General-*- on the subject of blood and blood products;

Recognizing the technical, managerial, financial and ethical complexities of the situation, particularly in developing countries;

Stressing the importance for Member States of developing national policies to ensure the timely and adequate supply of safe blood and blood products to all in n e e d , and of using blood and blood products rationally as appropriate to their country situation;

Pointing out the utility of making optimal use to this end of the technical and managerial information to be found in the relevant WHO publications;^

REQUESTS the Director-General:

(1) to support Member States, and in particular developing countries, in developing national policies for blood and blood products and in using them rationally;

(2) to update and make available to Member States, through appropriate WHO

publications, valid information on technological developments related to blood, blood products and blood substitutes, and oil appropriate and cost-effective ways of organizing blood transfusion services;

(3) to continue close collaboration with the appropriate nongovernmental organizations in supporting Member States in this field;

(4) to study the world situation further, and to report back to the Board on the implementation of this resolution.

Eleventh meeting, 17 January 1987 EB79/SR/11

1 Documents EB79/7 and EB79/7 Add.l.

2 See document EB79/7 A d d . l .

Références

Documents relatifs

The Industrial Organization of Financial Services in Developing and Developed Countries.. Paolo Casini February

It is not clear, though, whether a regulator like a central bank (or any other authority) has the power of enforcing any such decision rule. In our view, a regulator central bank

(6) to develop, provide and disseminate guidance and technical support to strengthen national coordinated blood and plasma programmes and introduction of blood component

Recalling resolution WHA58.13 on blood safety: proposal to establish World Blood Donor Day and preceding related resolutions since resolution WHA28.72 on utilization and supply

Working with countries to create sustainable blood and plasma programmes with appropriate regulatory systems will contribute to the following public health benefits: (a) optimal use

(b) improved safety and quality of blood products; (c) appropriate clinical use of blood products and safe transfusion practices; (d) sustainable and affordable supply of

(2) to advise and build capacity in Member States on leadership and management of blood supply systems in order to strengthen national coordinated and sustainable blood and

This study examined the nature of the ethical reasoning of auditors in Egypt, and aims to understand whether the levels of ethical reasoning is influenced by audit firm size